Clinical Trial: Prospective, Observational Diagnostic Validation Study of the SMARTwatch in Patients Presenting With Chest Pain for Diagnosis ST-segment Elevation Acute Myocardial Infarction

U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07780942) titled 'Prospective, Observational Diagnostic Validation Study of the SMARTwatch in Patients Presenting With Chest Pain for Diagnosis ST-segment Elevation Acute Myocardial Infarction' on Aug. 19.

Brief Summary: The main symptom that initiates the diagnostic and therapeutic process for patients with suspected acute coronary syndrome is chest pain. Based on a standard 12-lead electrocardiogram (ECG), patients can be diagnosed with ST-segment elevation myocardial infarction (STEMI), which requires immediate medical treatment. Recently, wearable devices like smartwatches with ECG capabilities have opened new pathways for cardiac triage, but the...